-
December 6, 2018 Lupin’s Tarapur facility receives EIR from US FDA
-
December 6, 2018 Lupin launches generic Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1%
-
December 6, 2018 Lupin launches generic Silodosin Capsules 4mg and 8mg
-
December 6, 2018 US FDA completes inspection of Lupin’s Mandideep location
-
December 5, 2018 Lupin receives FDA approval for Decitabine for Injection, 50 mg/vial, Single-Dose Vial
-
November 13, 2018 Lupin receives FDA approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL
-
November 12, 2018 Lupin launches generic Atovaquone Oral Suspension USP in the US
-
November 9, 2018 Lupin’s Nagpur facility receives EIR from US FDA
-
November 5, 2018 Lupin receives FDA approval for Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications